108 related articles for article (PubMed ID: 6761437)
1. Human peripheral blood monocyte and bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells.
Swinburne S; Cole P
J Reticuloendothel Soc; 1982 Nov; 32(5):371-85. PubMed ID: 6761437
[TBL] [Abstract][Full Text] [Related]
2. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.
Wright SC; Jewett A; Mitsuyasu R; Bonavida B
J Immunol; 1988 Jul; 141(1):99-104. PubMed ID: 3132506
[TBL] [Abstract][Full Text] [Related]
4. Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells.
Swinburne S; Moore M; Cole P
Cancer Immunol Immunother; 1985; 19(1):62-7. PubMed ID: 3844975
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of human pulmonary alveolar macrophages.
Kan-Mitchell J; Hengst JC; Kempf RA; Rothbart RK; Simons SM; Brooker AS; Kortes VL; Mitchell MS
Cancer Res; 1985 Jan; 45(1):453-8. PubMed ID: 3965151
[TBL] [Abstract][Full Text] [Related]
6. Innate-immune therapy for lung carcinoma based on tissue-macrophage activation with lipopolysaccharide.
Hino M; Kohchi C; Nishizawa T; Yoshida A; Nakata K; Inagawa H; Hori H; Makino K; Terada H; Soma G
Anticancer Res; 2005; 25(6A):3747-54. PubMed ID: 16302735
[TBL] [Abstract][Full Text] [Related]
7. Human lung macrophages enhance and inhibit lymphocyte proliferation.
Liu MC; Proud D; Schleimer RP; Plaut M
J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effector cell function at different stages of human monocyte-macrophage maturation.
Andreesen R; Osterholz J; Bross KJ; Schulz A; Luckenbach GA; Löhr GW
Cancer Res; 1983 Dec; 43(12 Pt 1):5931-6. PubMed ID: 6357433
[TBL] [Abstract][Full Text] [Related]
9. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.
Mavier P; Edgington TS
J Immunol; 1984 Apr; 132(4):1980-6. PubMed ID: 6321594
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS).
Cameron DJ; Churchill WH
J Immunol; 1980 Feb; 124(2):708-12. PubMed ID: 7356710
[TBL] [Abstract][Full Text] [Related]
11. [Cytostatic and growth-stimulating effects of alveolar macrophages of rats on tumor cells].
Hu LP; Gong YF; Wu DC
Shi Yan Sheng Wu Xue Bao; 1990 Jun; 23(2):213-7. PubMed ID: 2375208
[TBL] [Abstract][Full Text] [Related]
12. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
[TBL] [Abstract][Full Text] [Related]
13. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
Munn DH; Armstrong E
Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
[TBL] [Abstract][Full Text] [Related]
14. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of the generation of cell-mediated cytotoxicity after a single dose of adriamycin in cancer patients.
Arinaga S; Akiyoshi T; Tsuji H
Cancer Res; 1986 Aug; 46(8):4213-6. PubMed ID: 3488123
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
Baughman RP; Mangels DJ; Strohofer S; Corser BC
J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in tumor necrosis factor-alpha-dependent, monocyte-mediated leukemic cell death: a functional, morphologic, and flow-cytometric analysis.
van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; Dräger AM; Langenhuijsen MM
Exp Hematol; 1993 Dec; 21(13):1628-39. PubMed ID: 8243565
[TBL] [Abstract][Full Text] [Related]
18. [Cytotoxic action of natural killer cells on human tumor cells].
Avdeev GI; Viadro MM; Leĭkin IuD; Timofeevskaia EA; Osipov SG
Biull Eksp Biol Med; 1985 Apr; 99(4):471-3. PubMed ID: 3986372
[TBL] [Abstract][Full Text] [Related]
19. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing.
Martin JH; Edwards SW
J Immunol; 1993 Apr; 150(8 Pt 1):3478-86. PubMed ID: 8385686
[TBL] [Abstract][Full Text] [Related]
20. Laminin selectively enhances monocyte-macrophage-mediated tumoricidal activity.
Perri RT; Vercellotti G; McCarthy J; Vessella RL; Furcht LT
J Lab Clin Med; 1985 Jan; 105(1):30-5. PubMed ID: 3968463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
